Should You Buy Cross Country Healthcare Inc (CCRN) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
CCRN is not a good buy right now for a Beginner, long-term investor who wants to enter immediately. The stock’s technicals are only mildly constructive, but the fundamental trend is clearly deteriorating (2025/Q3 revenue down ~21% YoY and a swing to losses). With the Aya deal terminated, the story shifts to a slower, operational turnaround + buybacks, which is less compelling for an impatient long-term entry at ~$9.11 where analyst targets cluster around $9–$11.
Technical Analysis
Price/Trend: CCRN is trading at ~$9.115 (-0.87% today), sitting just above the pivot support area (Pivot ~8.91). This suggests the stock is not breaking down, but also not showing strong upside momentum.
Momentum: MACD histogram is positive (0.115) but “positively contracting,” implying bullish momentum is fading rather than accelerating. RSI(6) ~58 is neutral-to-slightly-bullish, not overbought and not a strong buy signal.
Moving averages: Converging moving averages typically indicate consolidation/chop rather than a clear trend—often a setup for a move, but direction is not confirmed.
Key levels: Support S1 ~8.535 (then S2 ~8.304). Resistance R1 ~9.284 (then R2 ~9.515). At $9.115, the stock is closer to resistance than deep-value support, so risk/reward for an immediate long-term buy is only average.
Pattern-based projection (given): Similar-candlestick stats imply modest upside bias (about +0.6% next day, +1.74% next week, +3.7% next month), which is not strong enough to override weakening fundamentals.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.